Aspegic 100

Contraindications

Hypersensitivity, peptic ulcer of the stomach and duodenum, increased bleeding, glucose−6-phosphate dehydrogenase deficiency, bronchial asthma.

Incompatibilities

Incompatible with anticoagulants. Increases the effect of NSAIDs and sulfonylurea derivatives, the toxicity of methotrexate. Reduces the effect of furosemide, spironolactone, anti-gout agents.

Pharmaceutical form

Powder for preparation of solution for injection

Undesirable effects

NSAIDs-gastropathy, gastrointestinal bleeding, thrombocytopenia, anemia, allergic reactions.

Therapeutic indications

Pain syndrome (myalgia, arthralgia, neuralgia, after surgery), fever, rheumatic diseases, neuritis, superficial vein thrombophlebitis, postoperative thrombosis and embolism.

Pharmacotherapeutic group

  • NSAIDs-Salicylic acid derivatives

Name of the medicinal product

Aspegic 100

Qualitative and quantitative composition

Lysine Acetylsalicylate

Dosage (Posology) and method of administration

In/in and deep in / m — 1-2 vials (no more than 10 g per day). The usual daily dose of acetylsalicylic acid for infants and children is 10-25 mg/kg of body weight, which corresponds to 0.1-0.25 ml of the finished solution for injection. This daily dose should be divided into 2-3 single doses. The solution must be prepared again each time.